Ra Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Ra Pharmaceuticals, Inc.
CIK #0001481512
EDGAR Form CIK 2011 - 2025
10-K [0001481512]
10-Q [0001481512]
3 [0001481512]
4 [0001481512]
8-K [0001481512]
D [0001481512]
SC 13D [0001481512]
SC 13G [0001481512]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc RA Pharmaceuticals Inc [2019-02-08]
Lightstone Ventures LP RA Pharmaceuticals Inc [2017-02-14]
Wellington Management Group LLP RA Pharmaceuticals Inc [2017-02-09]
RA Capital Management LLC RA Pharmaceuticals Inc [2016-11-09]
Morgenthaler Venture Partners IX LP RA Pharmaceuticals Inc [2016-11-07]
New Enterprise Associates 13 LP RA Pharmaceuticals Inc [2016-11-04]
Novo A/S RA Pharmaceuticals Inc [2016-11-03]
Novartis BioVentures Ltd RA Pharmaceuticals Inc [2016-10-31]
Form 3/4/5 Subject 2011 - 2025
Sandell Scott D
Kerins Patrick J
NEA 13 GP, Ltd
Baskett Forest
NEA Partners 13, Limited Partnership
Ra Pharmaceuticals, Inc.
New Enterprise Associates 13 LP
RA Capital Management LP
Kolchinsky Peter
RA Capital Healthcare Fund LP
Brennan Aoife
Mathers Edward T
Treco Douglas A
Lubner David Charles
Ricardo Alonso
Read Simon
Farzaneh-Far Ramin
Cumbo Alexander
Pearson Timothy R
King John C
Shah Rajeev M.
Heft Robert
Mott David M
Barris Peter J
Bisgaard Peter
Barrett M James
Viswanathan Ravi
Lettmann Jason
Novartis Bioventures Ltd
Novartis AG
Novo Holdings A/S
Morgenthaler Management Partners IX, LLC
Morgenthaler Venture Partners IX LP
Kolluri Krishna Kittu
Weller Harry R
Terms | Privacy | Guide
tony@aum13f.com